Andere talen Abpro Bio Co., Ltd.

Aandelen

A195990

KR7195990007

slotkoers Korea S.E. Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
511 ^KRW	-1,54%		+4,07%	-6,24%

2023	Abpro Bio Co. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023	CI
2022	Abpro Bio Co. (KOSDAQ:A195990) heeft de overname van 30,911846% belang in Zinitix Co., Ltd. (KOSDAQ:A303030) van Seoul Electronic Communication Co. (KOSDAQ:A303030) van Seoul Electronic Communication Co, Ltd., Wonwoo Kim, Soo-ah Kim.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.	16-12-22
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.	26-09-22
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding	24-12-21
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding	14-10-21
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm	18-06-21
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm	16-06-21
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion.	22-12-20
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd.	15-12-20
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.	26-11-20
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors	18-11-20
An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd..	25-10-20
Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. from Abpro Bio Co., Ltd..	23-10-20
Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.	22-10-20
Abpro Bio Co., Ltd.(KOSDAQ:A195990) added to S&P Global BMI Index	21-09-20
An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd. for KRW 3.2 billion.	31-12-19
Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. for KRW 6.8 billion.	29-11-19
Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in funding from Abpro Bio Co., Ltd.	18-11-19
Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding	14-11-19
Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding	31-10-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Abpro Bio Co., Ltd.

Aandelen

A195990

KR7195990007

Andere talen

Filters